Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209917) titled 'Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India' on Sept. 29.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Care Provider, Outcomes Assessor).

Primary Sponsor: University of California, Irvine

Condition: Cervical Cancer HPV Infection HIV Infection

Intervention: Behavioral: ASHA-Health HPV Intervention

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2025

Target Sample Size: 420

To know more, visit https://clinicaltria...